OLZ treatment in rats affected the 5mC levels of several genes associated with schizophrenia, including dopamine D1 receptor (DRD1), dopamine D2 receptor (DRD2), dopamine D5 receptor (DRD5), and others. This evidence concerns the gene DRD5 and schizophrenia.